2025-04-27
Evaluating the Immunogenic Potential of ApxI and ApxII from Actinobacillus pleuropneumoniae: An Immunoinformatics-Driven Study on mRNA Candidates
2025-04-27 • Yi Deng, Jiayong Chen, Yuhan Wang, Yu-Luo Wang, Jiale Liu, Zhihao Peng, Jiayu Zhou, Kun Lu, Xin Wen, Xiangyu Chen, See Tong Pang, Dan Wang, Mingxua...
Porcine infectious pleuropneumonia (PCP) caused by Actinobacillus pleuropneumoniae (APP) leads to severe economic losses in swine production. Commercial vaccines offer limited cross-protection for the 19 serotypes, while APP mRNA vaccines remain unexplored. This study evaluated eight candidate APP proteins (ApxI-IV, OlmA, TbpB, GalT, and GalU) using immunobioinformatics tools, and their immunogenicity and cross-protection were assessed in a mouse model. The results revealed that ApxI and ApxII excel due to their s…